Kerri A. Holick, Ph.D. - Publications
Affiliations: | 2006 | Columbia University, New York, NY |
Area:
SerotoninYear | Citation | Score | |||
---|---|---|---|---|---|
2008 | Holick KA, Lee DC, Hen R, Dulawa SC. Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 406-17. PMID 17429410 DOI: 10.1038/Sj.Npp.1301399 | 0.711 | |||
2004 | Dulawa SC, Holick KA, Gundersen B, Hen R. Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1321-30. PMID 15085085 DOI: 10.1038/Sj.Npp.1300433 | 0.684 | |||
Low-probability matches (unlikely to be authored by this person) | |||||
2003 | Guan Z, Kim JH, Lomvardas S, Holick K, Xu S, Kandel ER, Schwartz JH. p38 MAP kinase mediates both short-term and long-term synaptic depression in aplysia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 7317-25. PMID 12917365 DOI: 10.1523/Jneurosci.23-19-07317.2003 | 0.245 | |||
2007 | David DJ, Klemenhagen KC, Holick KA, Saxe MD, Mendez I, Santarelli L, Craig DA, Zhong H, Swanson CJ, Hegde LG, Ping XI, Dong D, Marzabadi MR, Gerald CP, Hen R. Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. The Journal of Pharmacology and Experimental Therapeutics. 321: 237-48. PMID 17237257 DOI: 10.1124/Jpet.106.109678 | 0.175 | |||
Hide low-probability matches. |